KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
Table 1
Demographic and clinical characteristics of SSc patients and CS.
SSc (%) ()
CS (%) ()
Age (years)
48.7 (18-75)
48.3 (20-73)
0.9
Gender
Female
88 (44)
94.4 (85)
0.2
Male
12 (6)
5.5 (5)
0.2
Disease subtype
lcSSc
86 (43)
—
dcSSc
14 (7)
—
Disease duration (months)
94.8 (3-420)
—
Clinical manifestations
Sclerodactyly
88 (44)
—
Musculoskeletal damage
82 (41)
—
Raynaud’s phenomenon
70 (35)
—
Puffy fingers
68 (34)
—
Telangiectasia
54 (27)
—
Digital ulcers
40 (20)
Clinical evaluation
HAQ
0.4 (0-1.29)
—
MRSS51
7.3 (0-30)
—
Data are shown in median and rank in parentheses. SSc: Systemic Sclerosis; CS: Control Subjects; HAQ: Health Assessment Questionnaire disability index; MRSS51: Modified Rodnan Skin Score. Mann–Whitney U test; Fisher’s test.